Skip to content
DraconiticResearch
Search Sources API
206,698 studies31 sourcesUpdated 30 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. CAR-NK cell immunotherapy: a comprehensive review of engineering platforms, clinical applications in hematological and solid tumors.
    Salma Mohamed Awadallah, NourEldin Elmesalamy, Ahmed Reda Bahr +3
    Journal of cancer research and clinical oncologyPeer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  2. Prognostic Significance and Clinical Robustness of the HALP Score in Super-Elderly Patients Undergoing Curative Gastrectomy for Gastric Cancer: A Multicenter Retrospective Cohort Study.
    Hiroyuki Inoue, Takeshi Kubota, Toshiyuki Kosuga +14
    Annals of gastroenterological surgeryPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  3. The Cost of Uncertainty: A Microcosting Analysis of the Cancer of Unknown Primary Diagnostic Pathway.
    Laura Spurgeon, Claire Mitchell, Alicia-Marie Conway +2
    BJC reportsPeer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  4. Electronic patient-reported outcome assessment at inpatient admission: a descriptive analysis of real-world data for 1423 radiotherapy patients.
    Maria Schollmeyer, Heike Schmidt, Jörg Andreas Müller +2
    Radiation oncology (London, England)Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  5. 3D tissue model to patient atlas: dynamic network topology reveals PDAC chemoresistance bottlenecks.
    Maryam Almasi, Jesús Guillermo Nieves Pereira, Thomas Dandekar +2
    NPJ systems biology and applicationsPeer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  6. Claudin 1 promotes blood-borne metastasis by modulating the Src/Ezrin signaling pathway in high-CLDN1 triple-negative breast cancer model
    Huiping Yang, Hong Lu, Wei Wang +4
    Molecular & Cellular OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCEurope PMCDOAJ
  7. Arginine vasopressin deficiency following pembrolizumab-induced hypophysitis: a case report and review of the literature
    Annina Rebecca Dold, Raphael Jeker, Michael Mark
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  8. A prognostic inflammation-nutrition reserve index for 180-day functional-survival outcomes after acute ischemic stroke in patients aged 80 years or older
    Lianhong Zhang, Jinghua Peng
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  9. Association between absolute lymphocyte count and outcomes of radiotherapy combined with immunotherapy in elderly patients with inoperable esophageal squamous cell carcinoma
    Youqin Jiang, Weiwei Chen, Daguang Ni +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  10. Clinicopathological and molecular characteristics of second primary colorectal cancer in cancer survivors including MSI-H status and anatomical distribution
    Yadong Liu, Xuejuan Duan, Shiwei Yang +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  11. The effectiveness of virtual reality–assisted relaxation therapy in improving psychological symptoms and fatigue of breast cancer survivors: a systematic review and meta-analysis
    Yu Deng, Ying Chen, Jiangling Mo +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  12. Diagnostic performance of deep learning models using ultrasound for preoperative axillary nodal status in breast cancer: a systematic review and meta-analysis
    Tianxin Liu, Xiaowu Yuan, Jinli Wang +8
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  13. Central-type primitive neuroectodermal tumor of the uterus: Case report and literature review
    Yi-Ying Lin, Ming-Yu Xie, Rong-Jun Mao +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  14. Pathological complete response and long-term outcomes after neoadjuvant therapy for breast cancer: a multicenter retrospective cohort study with exploratory subtype analyses
    Shaolong Fu, Kaiyang Xiao, Sibao Huang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  15. FLT3 expression and immune-associated transcriptional signatures in prostate cancer
    Yongqiang Cui, Tianmou Song, Xingyue Wang +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  16. SPP1-associated pathomics features for prognostic modeling in pancreatic ductal adenocarcinoma
    Jinming Zhao, Mingjun Li, Jialiang Xing +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  17. Case Report: Diagnostic pitfalls and individualized surgical management of borderline and malignant phyllodes tumors: a three-case series
    Chao Wang, Xiaowen Liu, Yuhang Wang +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  18. A comparison of 68Ga-PSMA PET/MR, 18F-FDG PET/CT and biochemical monitoring in neuroendocrine prostate cancer: a case report
    Yuqi Deng, Xin Li, Jie Hu +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  19. Prognostic prediction of pulmonary neuroendocrine carcinoma using a transformer-based artificial intelligence model: a two-center retrospective cohort study
    Lei Liu, Linchuan Liang, Dawei Wang +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  20. TACE-HAIC plus targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a systematic review and meta-analysis of TACE- and HAIC-based comparisons
    Peizhuo Li, Hao Li, Boyu Mei +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  21. Characterizing geospatial access to comprehensive breast cancer services in Northern Tanzania
    Tara M. Friebel-Klingner, Anne F. Rositch, Hari S. Iyer +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  22. Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report.
    Hishan Tharmaseelan, Christian Peter Jaworek, Peter Borchmann +10
    Cancer chemotherapy and pharmacologyPeer-reviewedCC BYFull textOncologyEurope PMC
  23. Advances in assessment systems and non-pharmacological intervention strategies for cancer-related fatigue following transarterial chemoembolization in hepatocellular carcinoma: a narrative review.
    Shiying Yang, Xuelei Yao, Yali Ren +3
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textOncologyEurope PMC
  24. Immune-related adverse reactions across multiple systems in a non-small cell lung cancer patient induced by immune checkpoint inhibitors: a case report and literature review
    Jing Li, Dan Wang, Lingli Zheng +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJEurope PMC
  25. An IL-21R STAT hypomorph circumvents functional redundancy in germinal centre responses.
    Christoph Jandl, Joanna Warren, Samantha Owens +3
    ELifePeer-reviewedCC BYFull textOncologyEurope PMCDOAJ